Integrated Hemophilia Platform Strategy and OperationsLead the development and execution of the Hemophilia integrated platform strategy to shape the rare disease policy, improve affordability, and upgrade treatment regimen to maximally improve the hemophilia patients’ lifelong benefits. Upgrade current initiatives, ie. HTC establishment, MDT, SDM (shared decision making) platform, aligning with Pfizer's rare disease franchise vision and integrating FVIII, FIX and non-factor products, to drive the achievement of key business metrics. Provide evidence-based tools and knowledge to healthcare providers, payers, charities, hospital directors, etc. to improve affordability.Explore innovative collaboration models to support business growth.Serve as the central hub between inline factor and non-factor brand team, coordinating resources (marketing, medical, access, etc.) to ensure effective execution.
Project Management and Impact EvaluationEstabli...